• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粗糙集在抗真菌咪唑鎓化合物构效关系分析中的应用

Rough sets in the analysis of the structure-activity relationships of antifungal imidazolium compounds.

作者信息

Krysiński J

机构信息

Chair of Pharmaceutical Technology, Medical Academy, Poznań, Poland.

出版信息

J Pharm Sci. 1995 Feb;84(2):243-8. doi: 10.1002/jps.2600840225.

DOI:10.1002/jps.2600840225
PMID:7738810
Abstract

The relationship between chemical structure and antifungal activity of quaternary imidazolium compounds is analyzed. The compounds are described by a set of condition attributes concerning structure and by a decision attribute concerning activity. The description builds up an information system. The smallest set of condition attributes, significant for high-quality classifications, has been found by using the rough sets approach. The analysis of the distribution of the value of the significant condition attributes in the best and the worst classes lead to the definition of typical representatives of the best and the worst imidazolium chlorides in terms of the significant condition attributes. A decision algorithm has been developed from the information system, presenting an important relationship between structure and antifungal activity. This may be helpful in supporting decisions concerning synthesis of new antifungal imidazolium compounds.

摘要

分析了季铵化咪唑化合物的化学结构与抗真菌活性之间的关系。这些化合物由一组关于结构的条件属性和一个关于活性的决策属性来描述。该描述构建了一个信息系统。通过使用粗糙集方法,找到了对于高质量分类具有重要意义的最小条件属性集。对最佳和最差类别中重要条件属性值的分布分析,得出了就重要条件属性而言最佳和最差氯化咪唑鎓的典型代表的定义。从该信息系统开发了一种决策算法,它呈现了结构与抗真菌活性之间的重要关系。这可能有助于支持有关新型抗真菌咪唑化合物合成的决策。

相似文献

1
Rough sets in the analysis of the structure-activity relationships of antifungal imidazolium compounds.粗糙集在抗真菌咪唑鎓化合物构效关系分析中的应用
J Pharm Sci. 1995 Feb;84(2):243-8. doi: 10.1002/jps.2600840225.
2
Rough sets approach to the analysis of the structure-activity relationship of quaternary imidazolium compounds.基于粗糙集方法分析季铵咪唑化合物的构效关系
Arzneimittelforschung. 1990 Jul;40(7):795-9.
3
[Application of the rough sets theory to the analysis of structure-activity relationships of pyridinium antifungal compounds].粗糙集理论在吡啶鎓类抗真菌化合物构效关系分析中的应用
Arch Pharm (Weinheim). 1994 Apr;327(4):247-54. doi: 10.1002/ardp.19943270410.
4
[Rough sets theory in structure-activity relationship analysis of quaternary pyridinium compounds].[粗糙集理论在季铵盐化合物构效关系分析中的应用]
Pharmazie. 1991 Dec;46(12):878-81.
5
[Rough sets theory in the analysis of structure-activity relationships of quaternary quinolinium- and isoquinolinium compounds].[粗糙集理论在季铵型喹啉和异喹啉化合物构效关系分析中的应用]
Arch Pharm (Weinheim). 1991 Nov;324(11):827-32. doi: 10.1002/ardp.2503241101.
6
Prediction of antifungal activity of gemini imidazolium compounds.双子咪唑鎓化合物抗真菌活性的预测
Biomed Res Int. 2015;2015:392326. doi: 10.1155/2015/392326. Epub 2015 Apr 15.
7
[Effect of new quaternary imino compounds against selected bacterial and fungal strains. 11. Synthesis of 1-methyl- and 1-ethyl-3-(n-alkoxymethyl)imidazolium chlorides].[新型季铵亚胺化合物对特定细菌和真菌菌株的作用。11. 1-甲基-和1-乙基-3-(正烷氧基甲基)咪唑鎓氯化物的合成]
Pharmazie. 1985 Aug;40(8):570-1.
8
Application of the rough sets theory to the analysis of structure-activity-relationships of antimicrobial pyridinium compounds.粗糙集理论在抗微生物吡啶化合物构效关系分析中的应用。
Pharmazie. 1995 Sep;50(9):593-7.
9
Structure-Activity Relationships of the Imidazolium Compounds as Antibacterials of and .作为抗菌剂的咪唑鎓化合物的结构-活性关系 。
Int J Mol Sci. 2021 Jul 27;22(15):7997. doi: 10.3390/ijms22157997.
10
[Activity of new iminium compounds against bacteria and fungi. 28. Synthesis of 1-ethyl-, 1-n-dodecyl-2-phenyl-3-(n-alkylthiomethyl)- and 1-ethyl-, 1-n-dodecyl-2-phenyl-3-(n-alkoxymethyl)imidazolium chlorides].[新型亚胺化合物对细菌和真菌的活性。28. 1-乙基-、1-正十二烷基-2-苯基-3-(正烷基硫代甲基)-和1-乙基-、1-正十二烷基-2-苯基-3-(正烷氧基甲基)氯化咪唑鎓的合成]
Pharmazie. 1992 Aug;47(8):623-6.